# Reading International Inc: financial statements, quarterly

RDI · Nasdaq · CIK 716634 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/rdi.md) · [Financials](/companies/rdi/financials.md) · [Filings](/companies/rdi/filings.md) · [Insiders](/companies/rdi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/rdi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [66.6](/filings/0000716634-25-000006.md) | [45.3 d](/filings/0000716634-26-000005.md) | [45.1](/filings/0000716634-25-000030.md) | [46.8](/filings/0000716634-25-000037.md) | [60.1](/filings/0000716634-25-000048.md) | [58.6 d](/filings/0000716634-26-000005.md) | [40.2](/filings/0000716634-26-000019.md) | [60.4](/filings/0000716634-26-000028.md) | [52.2](/filings/0000716634-25-000048.md) | [50.3 d](/filings/0000716634-26-000005.md) | [45.1](/filings/0000716634-26-000019.md) | [66.9](/filings/0000716634-26-000028.md) |
| Operating income | $m | [1.0](/filings/0000716634-25-000006.md) | [(7.0) d](/filings/0000716634-26-000005.md) | [(7.5)](/filings/0000716634-25-000030.md) | [(7.7)](/filings/0000716634-25-000037.md) | [(0.3)](/filings/0000716634-25-000048.md) | [1.5 d](/filings/0000716634-26-000005.md) | [(6.9)](/filings/0000716634-26-000019.md) | [2.9](/filings/0000716634-26-000028.md) | [(0.3)](/filings/0000716634-25-000048.md) | [(1.0) d](/filings/0000716634-26-000005.md) | [(3.6)](/filings/0000716634-26-000019.md) | [7.5](/filings/0000716634-26-000028.md) |
| Interest expense | $m | [5.1](/filings/0000716634-25-000006.md) | [5.4 d](/filings/0000716634-26-000005.md) | [5.3](/filings/0000716634-25-000030.md) | [5.4](/filings/0000716634-25-000037.md) | [5.2](/filings/0000716634-25-000048.md) | [5.2 d](/filings/0000716634-26-000005.md) | [4.7](/filings/0000716634-26-000019.md) | [4.4](/filings/0000716634-26-000028.md) | [4.2](/filings/0000716634-25-000048.md) | [4.7 d](/filings/0000716634-26-000005.md) | [4.2](/filings/0000716634-26-000019.md) | [4.3](/filings/0000716634-26-000028.md) |
| Income tax | $m | [0.9](/filings/0000716634-25-000006.md) | [0.3 d](/filings/0000716634-26-000005.md) | [(0.2)](/filings/0000716634-25-000030.md) | [(0.2)](/filings/0000716634-25-000037.md) | [0.7](/filings/0000716634-25-000048.md) | [0.2 d](/filings/0000716634-26-000005.md) | [(0.5)](/filings/0000716634-26-000019.md) | [1.2](/filings/0000716634-26-000028.md) | [0.3](/filings/0000716634-25-000048.md) | [(0.2) d](/filings/0000716634-26-000005.md) | [(0.1)](/filings/0000716634-26-000019.md) | [1.5](/filings/0000716634-26-000028.md) |
| Net income | $m | [(4.4)](/filings/0000716634-25-000006.md) | [(12.4) d](/filings/0000716634-26-000005.md) | [(13.2)](/filings/0000716634-25-000030.md) | [(12.8)](/filings/0000716634-25-000037.md) | [(7.0)](/filings/0000716634-25-000048.md) | [(2.2) d](/filings/0000716634-26-000005.md) | [(4.8)](/filings/0000716634-26-000019.md) | [(2.7)](/filings/0000716634-26-000028.md) | [(4.2)](/filings/0000716634-25-000048.md) | [(2.6) d](/filings/0000716634-26-000005.md) | [(8.1)](/filings/0000716634-26-000019.md) | [2.3](/filings/0000716634-26-000028.md) |
| Diluted EPS | $ per share | [(0.20)](/filings/0000716634-25-000006.md) | not reported | [(0.59)](/filings/0000716634-25-000030.md) | [(0.57)](/filings/0000716634-25-000037.md) | [(0.31)](/filings/0000716634-25-000048.md) | not reported | [(0.21)](/filings/0000716634-26-000019.md) | [(0.12)](/filings/0000716634-26-000028.md) | [(0.18)](/filings/0000716634-25-000048.md) | not reported | [(0.36)](/filings/0000716634-26-000019.md) | [0.10](/filings/0000716634-26-000028.md) |
| Basic EPS | $ per share | [(0.20)](/filings/0000716634-25-000006.md) | not reported | [(0.59)](/filings/0000716634-25-000030.md) | [(0.57)](/filings/0000716634-25-000037.md) | [(0.31)](/filings/0000716634-25-000048.md) | not reported | [(0.21)](/filings/0000716634-26-000019.md) | [(0.12)](/filings/0000716634-26-000028.md) | [(0.18)](/filings/0000716634-25-000048.md) | not reported | [(0.36)](/filings/0000716634-26-000019.md) | [0.10](/filings/0000716634-26-000028.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [11.9](/filings/0000716634-25-000006.md) | [12.9](/filings/0000716634-26-000005.md) | [7.5](/filings/0000716634-25-000030.md) | [9.2](/filings/0000716634-25-000037.md) | [10.1](/filings/0000716634-25-000048.md) | [12.3](/filings/0000716634-26-000005.md) | [5.9](/filings/0000716634-26-000019.md) | [9.1](/filings/0000716634-26-000028.md) | [8.1](/filings/0000716634-25-000048.md) | [10.5](/filings/0000716634-26-000028.md) | [5.5](/filings/0000716634-26-000019.md) | [5.7](/filings/0000716634-26-000028.md) |
| Current assets | $m | [41.5](/filings/0000716634-23-000031.md) | [38.7](/filings/0000716634-25-000008.md) | [20.3](/filings/0000716634-24-000018.md) | [58.7](/filings/0000716634-25-000004.md) | [59.0](/filings/0000716634-25-000006.md) | [57.0](/filings/0000716634-26-000005.md) | [33.1](/filings/0000716634-25-000030.md) | [21.3](/filings/0000716634-25-000037.md) | [18.8](/filings/0000716634-25-000048.md) | [21.8](/filings/0000716634-26-000028.md) | [44.8](/filings/0000716634-26-000019.md) | [47.1](/filings/0000716634-26-000028.md) |
| Total assets | $m | [533](/filings/0000716634-23-000031.md) | [533](/filings/0000716634-25-000008.md) | [495](/filings/0000716634-24-000018.md) | [495](/filings/0000716634-25-000004.md) | [496](/filings/0000716634-25-000006.md) | [471](/filings/0000716634-26-000005.md) | [441](/filings/0000716634-25-000030.md) | [438](/filings/0000716634-25-000037.md) | [435](/filings/0000716634-25-000048.md) | [435](/filings/0000716634-26-000028.md) | [431](/filings/0000716634-26-000019.md) | [429](/filings/0000716634-26-000028.md) |
| Current liabilities | $m | [127](/filings/0000716634-23-000031.md) | [127](/filings/0000716634-25-000008.md) | [135](/filings/0000716634-24-000018.md) | [152](/filings/0000716634-25-000004.md) | [143](/filings/0000716634-25-000006.md) | [162](/filings/0000716634-26-000005.md) | [142](/filings/0000716634-25-000030.md) | [130](/filings/0000716634-25-000037.md) | [111](/filings/0000716634-25-000048.md) | [129](/filings/0000716634-26-000028.md) | [131](/filings/0000716634-26-000019.md) | [204](/filings/0000716634-26-000028.md) |
| Total liabilities | $m | [491](/filings/0000716634-23-000031.md) | [500](/filings/0000716634-25-000008.md) | [477](/filings/0000716634-24-000018.md) | [489](/filings/0000716634-25-000004.md) | [495](/filings/0000716634-25-000006.md) | [476](/filings/0000716634-26-000005.md) | [450](/filings/0000716634-25-000030.md) | [447](/filings/0000716634-25-000037.md) | [448](/filings/0000716634-25-000048.md) | [453](/filings/0000716634-26-000028.md) | [457](/filings/0000716634-26-000019.md) | [453](/filings/0000716634-26-000028.md) |
| Long-term debt | $m | not reported | [210](/filings/0000716634-24-000009.md) | not reported | not reported | not reported | [203](/filings/0000716634-25-000008.md) | not reported | not reported | not reported | [185](/filings/0000716634-26-000005.md) | not reported | not reported |
| Current portion of debt | $m | [58.6](/filings/0000716634-23-000031.md) | [85.5](/filings/0000716634-24-000009.md) | [41.9](/filings/0000716634-24-000018.md) | [58.6](/filings/0000716634-25-000004.md) | [52.6](/filings/0000716634-25-000006.md) | [69.2](/filings/0000716634-25-000008.md) | [53.7](/filings/0000716634-25-000030.md) | [38.2](/filings/0000716634-25-000037.md) | [16.5](/filings/0000716634-25-000048.md) | [36.0](/filings/0000716634-26-000005.md) | [35.5](/filings/0000716634-26-000019.md) | [108](/filings/0000716634-26-000028.md) |
| Shareholders' equity | $m | [42.0](/filings/0000716634-23-000031.md) | [33.1](/filings/0000716634-25-000008.md) | [18.0](/filings/0000716634-24-000018.md) | [6.5](/filings/0000716634-25-000004.md) | [1.6](/filings/0000716634-25-000006.md) | [(4.4)](/filings/0000716634-26-000005.md) | [(8.1)](/filings/0000716634-25-000030.md) | [(7.7)](/filings/0000716634-25-000037.md) | [(12.1)](/filings/0000716634-25-000048.md) | [(18.2)](/filings/0000716634-26-000028.md) | [(25.5)](/filings/0000716634-26-000019.md) | [(23.3)](/filings/0000716634-26-000028.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Current portion of debt: us-gaap:DebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [2.4 d](/filings/0000716634-25-000006.md) | [(3.4) d](/filings/0000716634-26-000005.md) | [(2.8)](/filings/0000716634-25-000030.md) | [(10.4) d](/filings/0000716634-25-000037.md) | [1.3 d](/filings/0000716634-25-000048.md) | [8.0 d](/filings/0000716634-26-000005.md) | [(7.7)](/filings/0000716634-26-000019.md) | [1.6 d](/filings/0000716634-26-000028.md) | [0.3 d](/filings/0000716634-25-000048.md) | [4.3 d](/filings/0000716634-26-000005.md) | [(2.5)](/filings/0000716634-26-000019.md) | [3.1 d](/filings/0000716634-26-000028.md) |
| Capital expenditure | $m | [2.8 d](/filings/0000716634-25-000006.md) | [(1.7) d](/filings/0000716634-26-000005.md) | [1.9](/filings/0000716634-25-000030.md) | [0.2 d](/filings/0000716634-25-000037.md) | [2.4 d](/filings/0000716634-25-000048.md) | [1.0 d](/filings/0000716634-26-000005.md) | [0.3](/filings/0000716634-26-000019.md) | [0.4 d](/filings/0000716634-26-000028.md) | [0.5 d](/filings/0000716634-25-000048.md) | [0.2 d](/filings/0000716634-26-000005.md) | [0.5](/filings/0000716634-26-000019.md) | [0.9 d](/filings/0000716634-26-000028.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [22.0](/filings/0000716634-23-000031.md) | [22.1](/filings/0000716634-24-000018.md) | [23.5](/filings/0000716634-25-000004.md) | [23.5](/filings/0000716634-25-000006.md) | [22.3](/filings/0000716634-25-000030.md) | [22.4](/filings/0000716634-25-000037.md) | [22.4](/filings/0000716634-25-000048.md) | [22.4](/filings/0000716634-26-000019.md) | [22.7](/filings/0000716634-26-000028.md) | [22.7](/filings/0000716634-25-000048.md) | [22.7](/filings/0000716634-26-000019.md) | [23.8](/filings/0000716634-26-000028.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.